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Shprintzen, Ph.D.,2 and Wendy R. Kates, Ph.D.1,3,4

ABSTRACT
Mania and bipolar disorder have been reported in adolescents and adults with velocardiofacial
syndrome (VCFS; also known as 22q11.2 deletion syndrome). Children with VCFS have a high
prevalence of attention-deficit/hyperactivity disorder (ADHD), which may constitute a risk factor for the eventual development of bipolar disorder in this population. Therefore, we sought to
determine whether children with VCFS exhibit more manic symptoms than community controls
that also may have learning disorders and ADHD. The study population consisted of 86 children
with VCFS and 36 community controls from ages 9 to 15 years, using measures of Young Mania
Rating Scale–Parent Version, Schedule for Affective Disorders and Schizophrenia for SchoolAge Children–Present and Lifetime Version (K-SADS-PL), Child Behavior Checklist (CBCL),
and Wechsler Intelligence Scale for Children–3rd edition (WISC-III). The results indicate that
manic symptoms were not more prevalent in VCFS than in a community sample of children
with learning disorders and ADHD. However, after accounting for symptoms of depression and
ADHD, we found that manic symptoms in VCFS predicted uniquely to scores on four Child Behavior Checklist (CBCL) subscales, including anxiety, somatization, thought, and conduct problems. In contrast, manic symptoms in controls predicted uniquely to conduct problems only.
Accordingly, our findings of severe behavioral impairment in youth with VCFS and manic
symptoms suggest that these children may warrant more intensive monitoring and treatment
relative to youth with VCFS and ADHD only.
INTRODUCTION

V

(VCFS), also
known as 22q11.2 deletion syndrome, DiGeorge syndrome, and conotruncal anomalies
face syndrome, is a multiple anomaly disorder
that is caused by a microdeletion of DNA from
ELOCARDIOFACIAL

SYNDROME

chromosome 22 at the q11.2 band (Driscoll et al.
1992). Individuals with VCFS exhibit a highly
variable phenotype (Robin and Shprintzen
2005). Physical phenotypes include palate,
heart, renal, vascular, limb, brain, spine, and
immunologic anomalies (Robin and Shprintzen
2005). Language and motor delay occur in
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nearly all cases (Shprintzen 2000). Mild mental
retardation, persistent coordination deficits, and
poor academic performance are also common.
The deletion at chromosome 22q11.2 is also associated with a high frequency of behavioral
disorders during childhood, including attentiondeficit/hyperactivity disorder (ADHD), specific
phobias, and major depressive disorder (MDD;
Goldberg et al. 1993; Pulver et al. 1994; Karayiorgou et al. 1995; Papolos et al. 1996; McCandless
et al. 1998; Gothelf et al. 1999; Arnold et al.
2001; Feinstein et al. 2002; Antshel et al. 2006).
There is some evidence, however, to suggest
that the prevalence rates of several of these
psychiatric disorders in children with VCFS do
not differ significantly from cognitively matched
samples (Feinstein et al. 2002).
As children with VCFS move into adulthood,
several groups report high rates of schizophrenia (Murphy and Owen 1997; Bassett et al. 1999;
Murphy et al. 1999; Arnold et al. 2001; Pinquier
et al. 2001; Feinstein et al. 2002). Less commonly
reported is bipolar mood disorder (Papolos et al.
1996). Despite relatively few research reports of
bipolar disorder in adults with VCFS, however,
we are aware of many anecdotal reports of
mania and bipolar disorder in children with
VCFS. This discrepancy might be due to the
natural course of VCFS psychiatric phenotype.
In fact, the oldest patients in the study by
Papolos and colleagues had schizophrenia and
schizoaffective disorder, suggesting that the
nature and course of psychiatric illness in VCFS
patients is still not clear (Papolos et al. 1996).
Papolos and colleagues found that 64% of
patients with VCFS met Diagnostic and Statistical Manual for Mental Disorders, 3rd edition,
revised (DSM-III-R; American Psychiatric
Association 1987) criteria for a spectrum of
bipolar disorders with full syndromal onset in
late childhood or early adolescence [mean age
of onset  12 years, standard deviation (SD)  3]
(Papolos et al. 1996). In addition, 20% of children with bipolar disorder met DSM-III-R
criteria for ADHD, whereas 16% met criteria
for DSM-III-R attention-deficit disorder without hyperactivity. These findings suggest an
unusually strong association between VCFS
and early-onset bipolar disorder. The high comorbidity between ADHD and bipolar disorder
is consistent with other studies of bipolar youth
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(Biederman et al. 1996) and the familial association between the two disorders (Faraone et al.
2003; Faraone and Tsuang 2003).
As noted above, the most common psychiatric co-morbidity in children and adolescents
with VCFS is ADHD as found in 35–55% of the
cohort (Papolos et al. 1996; Arnold et al. 2001;
Feinstein et al. 2002; Antshel et al. 2006). In light
of the high incidence of ADHD in VCFS, the frequent association between ADHD and bipolar
disorder, and the potential risk for early onset
bipolar disorder in children with VCFS, we
were interested in whether children with VCFS
exhibit manic symptoms to a greater extent
than typically developing controls, and whether
manic symptoms in children with VCFS was
associated with a distinctive behavioral phenotype relative to our control sample.
There have been few systematic studies of
the overlap between ADHD and bipolar disorder due to the prevailing skepticism about the
very existence of childhood bipolar disease
(Goodwin and Jamison 1990) and the clinical
difficulties in distinguishing ADHD from
mania in children due, in part, to the overlap
in symptoms (Carlson 1984) and to the finding
that childhood mania may present differently
from its adult counterpart (Davis 1979;
McGlashan 1988; Biederman et al. 1995). Nonetheless, Biederman and colleagues (1995)
described a Child Behavior Checklist Pediatric
Bipolar Disorder (CBCL-PBD) profile that discriminated children with bipolar disorder
(many of whom also had ADHD) from ADHD
children who did not have bipolar disorder.
The profile accurately discriminated bipolar
from nonbipolar children (Faraone et al. 2005).
Similarly, other investigators have found that
the CBCL separates bipolar from ADHD
groups (Geller et al. 1998; Hazell et al. 1999).
Insofar as these findings suggest that childhood mania is distinguishable from childhood
ADHD, the present work sought to investigate
the extent to which manic symptoms accounted
for behavioral problems after accounting for the
effects of symptoms of ADHD and depression.
On the basis of this prior literature, we tested
two hypotheses: (1) Children with VCFS would
display more manic symptoms than community controls, and (2) in children with VCFS
(but not necessarily community controls), after
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accounting for the variance explained by symptoms of ADHD and depression, the presence of
manic symptoms (based on the Young Mania
Rating Scale–Parent Version), would account
for a significant portion of variance in scores on
the Anxiety, Social Problems, Thought Problems, and Aggression subscales of the CBCL.
METHODS
Participants
The study population consisted of 86 children
with VCFS (39 females; mean age  11.9, SD 
2.1) and 36 community controls (12 females;
mean age  12.0; SD  1.9). All children ranged
in age from 9 to 15 years. Children with VCFS
were recruited from the Center for the Diagnosis, Treatment, and Study of VCFS at SUNY–
Upstate Medical University. All children with
VCFS had a fluorescent in situ hybridization
(FISH)-confirmed deletion in the chromosome
22q11.2 region. Community controls were
recruited from a local public school district.
Because children with VCFS exhibit learning
disabilities and ADHD, we did not exclude the
presence of either learning disabilities (LD) or
ADHD from our control sample. In addition, we
specifically excluded children whose parents reported were in gifted classes, earned all “As”, or
read before the age of five. This resulted in a control sample in which LD and ADHD were overrepresented relative to the general population.
We reasoned that this strategy would enable us
to account for variance due to LD/ADHD in
general as opposed to variance due to VCFS per
se. Children with an identifiable neurological
condition other than VCFS (e.g., traumatic brain
injury, seizure disorder, birth weight below 2,500
grams as reported by parent) that is known to affect cognitive or neuropsychiatric function were
excluded from participation from both groups.
Informed consent/assent was obtained from
parents and children under protocols approved
by the institutional review board.
Measures
Young Mania Rating Scale–Parent Version
(YMRS): This is an 11-item scale in a Likertscale format. Items describe symptoms that
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are generally associated with mania, and parents are asked to choose the most appropriate description of their child. Comparisons
between parent ratings on this scale and clinical ratings based on standard psychiatric interviews indicate that the scale has adequate
discriminative validity (Gracious et al. 2002).
We used the summary score of the YMRS-P
as a continuous variable in our statistical
analyses.
Schedule for Affective Disorders and Schizophrenia
for School-Age Children–Present and Lifetime Version (K-SADS-PL): The K-SADS-PL is a semistructured diagnostic interview schedule that
provides Diagnostic of Statistical Manual of Mental Disorders, 4th edition (DSM-IV; American
Psychiatric Association 1994) psychiatric diagnoses, based on interviews with the child’s primary caregiver (almost always his/her mother)
and the child (Kaufman et al. 1997). Although
we made every attempt to interview the child
as well as the parent, the child often had difficulty responding; in these cases, the K-SADS-PL
data was based on the parent’s response. A child
psychiatrist or clinical child psychologist administered the K-SADS-PL. Interrater reliability, based on 12 interviews, was calculated with
the kappa coefficient, and was 0.91. The psychiatric status of this sample, based on the
analysis of the K-SADS-PL, has been described
in Antshel et al. (2006).
For the current report, we used K-SADS-PL
responses to develop dimensional scores for
depression and ADHD, which we entered into
our regression model. The K-SADS-PL consists
of both an extensive screening module and
five supplemental modules. The screening
module contains DSM-IV symptoms for each
specific diagnostic category. The interviewer
assigns scores for each symptom, indicating
whether the symptom is present, absent, or
present but at the subthreshold level. Generally, subthreshold symptoms are assigned
when the child is experiencing the symptom,
but at a less frequent or less intense level than
would warrant a threshold-level score. Because many children with VCFS are at risk for
psychiatric disorders, but are not necessarily
exhibiting all the symptoms that would warrant a definite diagnosis, we were interested in
identifying children whose parents reported
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either subthreshold- or threshold-level symptoms of depression or ADHD.
We used the depression and the ADHD
screening modules to develop dimensional
scores based on this instrument. For each screening module, we assigned scores of 1 for each
symptom item that was not present; scores of 2
for each subthreshold-level symptom that was
endorsed, and scores of 3 for each thresholdlevel symptom that was endorsed. Then we
summed all the scores, thereby deriving a dimensional score for depression and for ADHD.
These scores were entered into our regression
model, as described below.
Child Behavior Checklist (CBCL): Parents were
asked to complete the CBCL, a widely used
and reliable scale consisting of 113 items
(Achenbach 1991). We compared subscale scores
and a CBCL-PBD score between study groups.
To derive the CBCL-PBD scores, following the
guidelines of Faraone and colleagues (2005), we
summed the scaled scores for anxiety, depression, attention and aggression.
Wechsler Intelligence Scale for Children–3rd edition (WISC-III): The WISC-III is comprised of 13
subtests (Wechsler 1991). The current analyses
only utilized the general measure of intellectual
functioning, the Full Scale IQ (FSIQ).
Wechsler Individual Achievement Test–2nd edition (WIAT-II): The WIAT-II (Wechsler 2001) is
an individually administered test of academic
achievement, which has been standardized with
4,252 children in grades K–12. This test contains
nine subtests, which are aggregated into four
composite scores: Reading, mathematics, language, writing, and an omnibus total score (M 
100, SD  15). For the present analyses, only the
total scores were used. These total scores were
used to operationalize a learning disability. A
designation of learning disability was based on a
1.5 S.D. discrepancy between the FSIQ of the
WISC-III and the WIAT-II total score or a WIAT-II
total score of  85.
Statistical analyses
Univariate and Chi-square analyses were
conducted to compare the study groups on
intelligence quotient (IQ) scores, gender ratio,
socioeconomic status (SES), and presence of
learning disabilities. Univariate analyses were
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conducted to determine if study groups differed in scores on the YMRS-P and the CBCLPBD profile. A multivariate analysis of
variance (MANOVA) was conducted to compare CBCL subscale scores between participants with VCFS and controls. A stepwise
regression model was used to determine the
degree to which manic symptoms (based on
the summary score of the YMRS-P) were predictive of subscale scores on the CBCL, after
controlling for the variance accounted for by
the presence of symptoms of depression and
ADHD (based on K-SADS dimensional scores).
The three predictors (symptoms of mania,
depression, and ADHD) were entered into the
model as a block, using the stepwise command.
(Prior to the regression analyses, initial linear
regressions were conducted to determine the
extent to which FSIQ, SES, and age were significant predictors of CBCL subscale scores. The
significant predictors were entered as the first
step in the stepwise regression model.)

RESULTS
As shown in Table 1, study groups did not
differ in either age [F(1, 121)  0.022; p  0.88,
or gender-ratios, 2  1.51; p  0.22]. Socioeconomic status was significantly lower in the
control group [F(1, 99)  4.39; p  0.04], and
FSIQ was significantly lower in the children
with VCFS [F(1, 121)  84.21; p  0.001, 2 
0.41]. As noted above, K-SADS-PL–based diagnoses of study participants have been described elsewhere.
The omnibus MANOVA on the CBCL scales
was significant [Wilks   0.765, F(11, 103) 
2.87, p  0.002, 2  0.24]. Follow-up univariate analyses revealed that the two groups differed on several CBCL subscales, including
Somatic Complaints [F(1, 120)  5.63, p  0.019,
2  0.05], Social Problems [F(1, 120)  11.58, p
 0.001, 2  0.09], Thought Problems [F(1, 120)
 6.56, p  0.012, 2  0.06]. Across all subscales, parents of children with VCFS rated their
child as having more behavioral difficulties.
(See Table 1 for complete group mean scores.)
Because the study groups differed in SES
and FSIQ, both variables were entered as covariates in the analysis of group differences in
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TABLE 1. DESCRIPTIVE DATA

Age
Sex (%male)
Socioeconomic status
Participants taking
medication (%)
Antidepressants
(% of sample)
Mood stabilizers
Stimulants/atomoxetine
Atypical antipsychotics
WISC-III Full Scale IQ
Incidence of learning
disabilities
YMRS Summary Score
CBCL Anxiety T score
CBCL Depression T score
CBCL Somatic Complaints
T score
CBCL Social Problems
T score
CBCL Thought Problems
T score
CBCL Attention Problems
T score
CBCL Rule-Breaking
T score
CBCL Aggression
T score
CBCL Internalizing
T score
CBCL Externalizing
T score
CBCL Total T score

VCFS
(n  86)

Control
(n  36)

11.9 (2.1)
55
47.5 (12.5)a
34

11.9 (1.9)
67
41.6 (13.8)
31

4.6

5.5

6.0
18.6
3.4
70.5 (13.2)b
63 (75%)b

5.5
19.4
0
94.8 (13.7)
14 (37.8%)

8.0 (8.1)
60.8 (8.8)
61.9 (9.0)
62.2 (9.6)c

7.0 (6.1)
58.9 (8.8)
59.7 (11.3)
57.7 (8.7)

65.9 (9.2)b

59.4 (10.1)

63.4 (9.4)a

58.6 (8.9)

65.9 (8.9)

62.8 (12.4)

57.3 (7.1)

54.7 (7.0)

60.0 (9.6)

56.9 (8.3)

62.6 (10.0)c

56.0 (14.0)

57.7 (9.7)a

53.0 (9.9)

63.7 (8.4)b

56.8 (11.8)

Socioeconomic status was measured by the Hollingshead
(1975) scale.
VCFS  Velocardiofacial syndrome; WISC-III  Wechsler
Intelligence Scale for Children–3rd edition (Wechsler, 1991);
YMRS  Young Mania Rating Scale–Parent Version
(Gracious et al., 2002); CBCL  Child Behavior Checklist
(Achenbach, 1991).
ap  0.05.
bp  0.001.
cp  0.01.

YMRS-P scores. This analysis indicated that
groups did not differ in number of manic
symptoms, on the basis of scores on the YMRSP [F(1, 113)  0.09; p  0.77; 2  0.01]. Similarly, although scores on the CBCL-PBD profile
tended to be higher for the VCFS sample than
those of controls [F(1,113)  3.08; p  0.08; 2 
0.03], differences were negligible once SES and

FSIQ were entered as co-variates [F(1,113) 
0.00; p  1.0].
The results of stepwise regression analyses on
CBCL subscale scores are reported in Tables 2
and 3. Prior to conducting stepwise regression
analyses, simple linear regressions were conducted to determine the extent to which FSIQ,
SES, and age were significant predictors of CBCL
subscale scores. SES was not a significant predictor of CBCL scores for either group. Age was a
significant predictor of depression in children
with VCFS, but not controls. FSIQ was a significant predictor of social and thought problems in
controls, but not in children with VCFS. Accordingly, for children with VCFS, age was entered in
the first block of predictors of CBCL–Depression.
Similarly, for controls, FSIQ was entered in the
first block of predictors of CBCL–Social Problems and CBCL–Thought Problems.
In children with VCFS, the presence of
manic symptoms was the only significant predictor of CBCL subscale scores on anxiety (accounting for 9.5% of the variance), somatization
(10%), thought problems (23%), and rule breaking (23%). Both manic and ADHD symptoms
were significant predictors of scores on social
problems (accounting for 21% and 8% of the
variance, respectively) and attention (11% and
12.7% of variance, respectively). Manic, ADHD,
and depression symptoms all were significant
predictors of scores on aggression. Manic symptoms accounted for over 30% of the variance in
scores on aggression. Depression and ADHD
symptoms accounted for only 5% and 4% of the
variance, respectively.
In our sample of community controls, the
presence of manic symptoms was the only significant predictor of CBCL subscale scores rule
breaking (accounting for 20%). FSIQ and manic
symptoms were predictors of scores on social
problems, accounting for 15% and 11% of the
variance, respectively. Both manic and ADHD
symptoms were significant predictors of scores
on anxiety (accounting for 21% and 11% of the
variance, respectively). Both manic and depression symptoms were significant predictors of
somatization (accounting for 9% and 24% of the
variance, respectively) and aggression (31% and
13% of variance, respectively). FSIQ as well as
manic, ADHD, and depression symptoms were
significant predictors of scores on thought
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TABLE 2. SIGNIFICANT PREDICTORS OF CBCL SUBSCALES IN VCFS SAMPLE FROM SCORES ON YMRS AND DIMENSIONAL
SCORES OF DEPRESSION AND ADHD FROM K-SADS-PL
Subscales
Anxiety
Depression
Somatization
Social Problems
Thought Problems
Attention
Rule Breaking
Aggression

Age/symptom predictors

Beta

T score

P value

Mania
Age
Depression
Mania
Mania
ADHD
Mania
ADHD
Mania
Mania
Mania
Depression
ADHD

0.31
0.25
0.32
0.32
0.45
0.29
0.48
0.35
0.34
0.48
0.45
0.24
0.19

2.77
2.22
2.80
2.86
4.59
2.91
4.70
3.39
3.27
4.71
4.45
2.31
2.04

0.007
0.03
0.007
0.006
0.000
0.005
0.000
0.001
0.002
0.000
0.000
0.024
0.045

R2 change
0.095
0.161
0.082
0.101
0.213
0.083
0.232
0.127
0.113
0.233
0.305
0.052
0.036

CBCL  Child Behavior Checklist; VCFS  velocardiofacial syndrome; YMRS  Young Mania Rating Scale–Parent
Version; ADHD  Attention-deficit/hyperactivity disorder; K-SADS-PL  Schedule for Affective Disorders and
Schizophrenia for School-Age Children–Present and Lifetime Version.

problems, accounting for 32%, 22%, 14%, and
8% of the variance, respectively. Complete regression results can be seen in Tables 2 and 3.
Because age was a significant predictor of
depression in our group of youth with VCFS,
we conducted a follow-up logistic regression
analysis in which presence or absence of
depression (based on the K-SADS-PL) was
entered as the outcome variable, and Study
Group, Age, and Study Group  Age were entered as the predictors. The overall significance
of the model was calculated with the Wald
statistic, which was significant (52.5; p  0.000).

The Study Group  Age interaction variable
was the only significant predictor (Wald statistic, 4.9; p  0.027), indicating that older children with VCFS, but not older controls, had a
higher incidence of depression.
DISCUSSION
In this sizeable sample of youth with VCFS,
we found that relative to controls, VCFS
participants were rated as having significantly elevated scores on the CBCL subscales of

TABLE 3. SIGNIFICANT PREDICTORS OF CBCL SUBSCALES IN CONTROL SAMPLE FROM SCORES ON YMRS AND DIMENSIONAL
SCORES OF DEPRESSION AND ADHD FROM K-SADS-PL
Subscales

Age/symptom predictors

Beta

T score

P value

R2 change

Anxiety

Mania
ADHD
Depression
Depression
Mania
Mania
FSIQ
ADHD
Depression
Mania
ADHD
Mania
Mania

0.38
0.35
0.42
0.42
0.32
0.36
0.35
0.39
0.34
0.32
0.58
0.45
0.47

2.51
2.27
2.65
2.78
2.09
2.17
3.50
4.17
3.54
3.12
4.01
2.85
3.45

0.017
0.03
0.012
0.009
0.045
0.038
0.002
0.000
0.001
0.004
0.000
0.007
0.002

0.206
0.114
0.180
0.242
0.094
0.112
0.320
0.216
0.140
0.081
0.335
0.203
0.316

Depression
Somatization
Social Problems
Thought Problems

Attention
Rule Breaking
Aggression

CBCL  Child Behavior Checklist; YMRS  Young Mania Rating Scale–Parent Version; ADHD  attention-deficit/
hyperactivity disorder; K-SADS-PL  Schedule for Affective Disorders and Schizophrenia for School-Age Children–
Present and Lifetime Version.
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somatization, social problems, and thought
problems. Despite the anecdotal reports of
increased risk for manic symptoms in children
with VCFS, our data suggest that manic symptoms (as measured by both the YMRS-P and
the CBCL-PBD profile) do not appear to be
more prevalent in VCFS than in a community
sample of children with learning disorders
and ADHD. Moreover, with the exception of
thought problems and anxiety, manic symptoms appear to account for comparable
portions of the variance in behavioral problems across both VCFS and control samples.
However, in VCFS, the presence of manic
symptoms is the only predictor of scores on
four CBCL subscales. The presence of manic
symptoms alone results in increased levels of
anxiety, somatization, thought problems, and
conduct problems. In contrast, the presence
of manic symptoms in controls only predicts
uniquely to conduct problems (rule breaking). In addition, it is noteworthy that manic
symptoms in VCFS predict specifically to
scores on two of the three subscales (somatization and thought problems) that are elevated
relative to controls.
This suggests that, in controls, depression
and ADHD symptoms must be present in conjunction with manic symptoms to be predictive of behavioral disturbance. This raises the
question of whether manic symptoms can be
reliably distinguished from ADHD symptoms
in individuals with nonsyndromic learning
disabilities. Co-morbidity between ADHD and
bipolar disorder has been noted frequently
(Wozniak 2005) in nonlearning–disabled samples. Although there is some overlap between
the diagnostic criterion sets for ADHD and
mania (e.g., distractibility), most of the diagnostic criteria do not overlap and some research shows that the overlapping criteria
typically do not confound the diagnostic process (Milberger et al. 1995). Clinicians must,
however, be careful not to confuse symptoms
of behavioral dysregulation or low tolerance
for frustration for manic symptoms; this can
be avoided by careful adherence to DSM-IV
criteria. Few studies have directly compared
the neuropsychological profile of youth with
bipolar disorder to those with ADHD (Doyle
et al. 2005). However, because executive
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dysfunction is common to both groups
(Dickstein et al. 2004; Doyle et al. 2005; Seidman
2006), and is also present in many children
with learning disabilities (Gioia et al. 2002),
the task of distinguishing between manic
symptoms and ADHD symptoms may be particularly challenging in children with learning
disabilities.
In contrast to controls, the presence of manic
symptoms in children with VCFS places children with this disorder at risk for behavioral
disturbance over and above the presence of
either depression symptoms or ADHD symptoms. This appears to be independent of the
positive relationship between depressive symptoms and age in youth with VCFS. Moreover,
the presence of manic symptoms in children
with VCFS is predictive of both internalizing
and externalizing disorders, suggesting that
manic symptoms result in greater overall behavioral dysregulation. In contrast, ADHD
symptoms do not predict to this degree of
behavioral dysregulation, suggesting that in
VCFS, manic symptoms may constitute a phenotype that is distinct from, and potentially
more severe than, an ADHD phenotype.
Because pervasive behavioral dysregulation
during childhood is associated with later psychopathology (Verhulste and Van der Ende
1995; Biederman et al. 2001), our findings suggest that the presence of manic symptoms in
children with VCFS may increase their vulnerability to continued psychiatric problems to a
greater extent than the presence of either
depression or ADHD symptoms.
VCFS is associated with intellectual delays;
epidemiological research suggests that psychiatric disorders are four to five times higher in
children with mental retardation compared to
typically developing children (Rutter et al.
1976; Koller et al. 1983). Nonetheless, these
data do not explain our interesting finding
that older children with VCFS, but not older
controls, had a higher incidence of depression.
The age association in VCFS may be related to
poor psychosocial adjustment and peer difficulties; as children get older, they become increasingly dependent on the peer group and
broader social milieu for learning about themselves and the world around them (Berndt
1996). Given that social difficulties are nearly
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ubiquitous in VCFS (Swillen et al. 1999; Prinzie
et al. 2002), it is possible that increasing social
difficulties during adolescence heighten the
risk for depressive symptoms. Future prospective research should address the extent to
which social difficulties presage the onset of
depressive symptoms in youth with VCFS.
These findings may have important clinical
implications for the treatment of children
with VCFS. Early assessment, diagnosis, and
treatment of manic symptoms is critical to
children with this disorder. It is essential that
clinicians consider and integrate the behavioral and the neuropsychological correlates of
manic symptoms while formulating appropriate intervention strategies. Early identification of manic symptoms in children with
VCFS, and provision of appropriate interventions, may help to mitigate the relatively severe emotional and behavioral dysregulation
that appears to accompany manic symptoms
in children with this disorder. Hence, future
psychosocial development may be enhanced
and further psychiatric deterioration potentially minimized.
Our interpretation of these data is tempered, however, by the finding that, although
manic symptoms are unique predictors of
several CBCL subscales in children with
VCFS, the overall predictive power of the
model is not as strong for children with VCFS
as for controls. For example, although the
presence of manic symptoms is uniquely associated with thought problems on the CBCL
in children with VCFS, it accounts for only
23% of the overall variance in thought problem scores. In contrast, in controls, the combination of FSIQ and symptoms of depression,
ADHD, and mania account for 76% of the
overall variance in thought problem scores.
Similarly, whereas mania is the unique predictor of anxiety scores in children with
VCFS, accounting for 10% of the total variance, the combination of symptoms of mania
and ADHD in controls accounts for 32% of
the overall variance in anxiety scores. This
pattern is similar for somatization scores as
well. This suggests that, although manic
symptoms increase vulnerability to anxiety,
somatization and thought problems in children with VCFS to a greater extent than
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symptoms of depression or ADHD, manic
symptoms still account for a smaller portion
of the variance than would be expected based
on our control sample. Moreover, our data
suggest that age and FSIQ are not contributing significantly to variance in CBCL scores in
children with VCFS. This raises the important
question of what is accounting for the relatively severe behavioral phenotype (characterized by increased levels of somatization,
social problems, and thought problems) that
children with VCFS exhibit relative to controls. Several recent reports suggest that allelic variation in the COMT gene, one copy of
which is deleted in VCFS, may be accounting
for the behavioral/psychiatric phenotype in
VCFS (Bearden et al. 2004; Bearden et al. 2005;
Gothelf et al. 2005). However, these findings
are inconsistent, and therefore additional
studies of genetic and environmental predictors are warranted.
Despite this potential caveat, the children
in the current sample will be returning for
follow-up in 3 years. At that time, we will be
able to determine whether the natural course
of manic symptoms in children with this
disorder differs from controls. We will also
investigate whether the cluster of manic
symptoms, behavioral dysregulation, and executive dysfunction that a subset of our sample currently displays are associated with the
onset of more severe psychiatric disorder,
and, if so, what the nature of that disorder is.
Regardless of the nature of eventual risk,
however, our findings of the presence of relatively severe behavioral impairment in youth
with VCFS and manic symptoms suggests
that this subset of children warrants careful
monitoring and treatment.
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